Training in Cardiovascular Research
心血管研究培训
基本信息
- 批准号:10626716
- 负责人:
- 金额:$ 46.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT ABSTRACT
Cardiovascular disease is the leading cause of death in the United States. There is an ongoing need to
provide multidisciplinary training for physician and PhD investigators who will devote a significant
component of their professional activity to understanding the pathophysiology and treatment of
cardiovascular disease. This is the 7th renewal application for the University of Utah (UofU) Cardiovascular
Research Training Program. Since its inception in 1984, this program has trained 113 individuals who have
largely gone on to pursue research careers. During the last training period (2016-2020), this training grant
supported 21 post-doctoral research trainees (5 MD/DOs, 16 PhDs) who all remain active at academic
institutions. Our trainees have authored 218 publications, with an average of 2 first-author publications
each. They have also received several grants and career development awards (e.g. NIH, American Heart
Association, NSF, ACS). This program continues to build on our unique strengths in cardiovascular
research at the UofU, spanning basic and mechanistic investigation across a range of model systems and
translational studies in humans. This training program unifies the three major cardiovascular research
centers at the UofU Health Sciences Center: The Nora Eccles Harrison Cardiovascular Research and
Training Institute (CVRTI), the Division of Cardiovascular Medicine at the School of Medicine, and the
Molecular Medicine Program (U2M2) at the Eccles Institute of Human Genetics. This training program
spans 13 UofU departments and includes 54 well-funded faculty mentors who lead exciting and productive
cardiovascular research programs. Each trainee will participate in a two-year training program that includes
a research project with a multidisciplinary mentoring committee, didactic coursework, and professional
development opportunities. With this renewal application, we continue to request support to prepare 8
postdoctoral trainees to be leaders in cardiovascular research. The next stage of the training program will
utilize an expanded mentor pool and implement a dual-leadership structure by two cardiology physician-
scientists (MPIs: Stavros Drakos, MD, PhD, and Robin Shaw, MD, PhD) whose interests span from basic
biochemistry to clinical trials. This renewal occurs at a time with the UofU is increasing its already sizeable
investment into cardiovascular research training. A $6M addition to the CVRTI is being constructed to
increase the number of cardiovascular research laboratories in an institute already fully dedicated to
cardiovascular research and training. Also there is a campus-wide Cardiovascular Strategic Plan being
implemented to enhance cardiovascular research and care and the UofU. The next five years of the training
program will leverage these new resources and opportunities at the UofU and represents a new era of
interdisciplinary collaborative cardiovascular research at our institution.
项目摘要
心血管疾病是美国死亡的主要原因。持续不断
为医师和博士调查人员提供多学科培训,他们将致力于重要
他们专业活动的组成部分,以了解
心血管疾病。这是犹他大学(UOFU)心血管的第七次续签申请
研究培训计划。自1984年成立以来,该计划已经培训了113个人
在很大程度上继续从事研究职业。在最后一个培训期(2016-2020),这项培训补助金
支持21名博士后研究学员(5个MD/DOS,16位博士学位),他们都活跃于学术
机构。我们的受训者撰写了218个出版物,平均有2个第一专人出版物
每个。他们还获得了几项赠款和职业发展奖(例如NIH,美国心脏
协会,NSF,ACS)。该计划继续以我们在心血管中的独特优势为基础
UOFU的研究,跨越了一系列模型系统的基本和机械调查
人类的翻译研究。该培训计划统一了三个主要的心血管研究
UOFU健康科学中心的中心:Nora Eccles Harrison Harrison心血管研究和
培训研究所(CVRTI),医学院心血管医学部门,
Eccles人类遗传学研究所的分子医学计划(U2M2)。这个培训计划
跨越13个UOFU部门,包括54位资金丰富的教师导师,他们领导了令人兴奋和富有成效的
心血管研究计划。每个学员将参加一项为期两年的培训计划,包括
由多学科指导委员会,教学课程和专业的研究项目
发展机会。通过此续订申请,我们继续请求支持8
博士后学员将成为心血管研究的领导者。培训计划的下一个阶段将
利用扩展的导师池并通过两个心脏病医师实施双重领导结构
科学家(MPI:Stavros Drakos,医学博士,博士学位和Robin Shaw,MD,PhD),他们的兴趣来自基本
临床试验的生物化学。这种续约一次发生在UOFU中,它已经增加了很大
投资心血管研究培训。 CVRTI的增加了600万美元
增加已经完全致力于的研究所的心血管研究实验室的数量
心血管研究和培训。还有一个范围内的心血管战略计划
实施以增强心血管研究和护理以及UOFU。接下来的培训五年
计划将利用UOFU的这些新资源和机会,代表
我们机构的跨学科协作心血管研究。
项目成果
期刊论文数量(185)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Meningeal cells and glia establish a permissive environment for axon regeneration after spinal cord injury in newts.
- DOI:10.1186/1749-8104-6-1
- 发表时间:2011-01-04
- 期刊:
- 影响因子:3.6
- 作者:Zukor KA;Kent DT;Odelberg SJ
- 通讯作者:Odelberg SJ
The small GTPase ARF6 stimulates β-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis.
- DOI:10.1126/scisignal.2003398
- 发表时间:2013-03-05
- 期刊:
- 影响因子:7.3
- 作者:Grossmann AH;Yoo JH;Clancy J;Sorensen LK;Sedgwick A;Tong Z;Ostanin K;Rogers A;Grossmann KF;Tripp SR;Thomas KR;D'Souza-Schorey C;Odelberg SJ;Li DY
- 通讯作者:Li DY
Canine Model of Ischemia-Induced Ventricular Tachycardia.
缺血引起的室性心动过速的犬模型。
- DOI:10.1016/j.jss.2023.09.003
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Hirahara,AnnieM;Khan,MuhammadS;Ishidoya,Yuki;Smego,Douglas;Roman,Orvelin;Ranjan,Ravi;Krueger,Lauren;Hoareau,Guillaume;Selzman,CraigH;Dosdall,DerekJ
- 通讯作者:Dosdall,DerekJ
Author Correction: Mitochondrial calcium uniporter stabilization preserves energetic homeostasis during Complex I impairment.
- DOI:10.1038/s41467-022-31304-5
- 发表时间:2022-06-20
- 期刊:
- 影响因子:16.6
- 作者:
- 通讯作者:
Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation.
- DOI:10.1002/nbm.3200
- 发表时间:2014-11
- 期刊:
- 影响因子:2.9
- 作者:Abdullah, Osama M.;Drakos, Stavros G.;Diakos, Nikolaos A.;Wever-Pinzon, Omar;Kfoury, Abdallah G.;Stehlik, Josef;Selzman, Craig H.;Reid, Bruce B.;Brunisholz, Kim;Verma, Divya Ratan;Myrick, Craig;Sachse, Frank B.;Li, Dean Y.;Hsu, Edward W.
- 通讯作者:Hsu, Edward W.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stavros George Drakos其他文献
Stavros George Drakos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stavros George Drakos', 18)}}的其他基金
Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Mitral Regurgitation
二尖瓣反流继发偏心心肌细胞肥大的机制
- 批准号:
10565204 - 财政年份:2023
- 资助金额:
$ 46.16万 - 项目类别:
Perm1 is a Novel Regulator of Cardiac Energetics and Function
Perm1 是一种新型的心脏能量和功能调节剂
- 批准号:
10547828 - 财政年份:2020
- 资助金额:
$ 46.16万 - 项目类别:
Perm1 is a Novel Regulator of Cardiac Energetics and Function
Perm1 是一种新型的心脏能量和功能调节剂
- 批准号:
10631449 - 财政年份:2020
- 资助金额:
$ 46.16万 - 项目类别:
Perm1 is a Novel Regulator of Cardiac Energetics and Function
Perm1 是一种新型的心脏能量和功能调节剂
- 批准号:
10730363 - 财政年份:2020
- 资助金额:
$ 46.16万 - 项目类别:
Perm1 is a Novel Regulator of Cardiac Energetics and Function
Perm1 是一种新型的心脏能量和功能调节剂
- 批准号:
10523981 - 财政年份:2020
- 资助金额:
$ 46.16万 - 项目类别:
Perm1 is a Novel Regulator of Cardiac Energetics and Function
Perm1 是一种新型的心脏能量和功能调节剂
- 批准号:
10156104 - 财政年份:2020
- 资助金额:
$ 46.16万 - 项目类别:
Understanding Myocardial Recovery in Diabetes and Heart Failure
了解糖尿病和心力衰竭的心肌恢复
- 批准号:
10426081 - 财政年份:2020
- 资助金额:
$ 46.16万 - 项目类别:
Understanding Myocardial Recovery in Diabetes and Heart Failure
了解糖尿病和心力衰竭的心肌恢复
- 批准号:
10595643 - 财政年份:2020
- 资助金额:
$ 46.16万 - 项目类别:
Clinical and Metabolic Signature of Recovered Myocardium in Human Heart Failure
人类心力衰竭恢复心肌的临床和代谢特征
- 批准号:
9218590 - 财政年份:2016
- 资助金额:
$ 46.16万 - 项目类别:
Clinical and Metabolic Signature of Recovered Myocardium in Human Heart Failure
人类心力衰竭恢复心肌的临床和代谢特征
- 批准号:
10066362 - 财政年份:2016
- 资助金额:
$ 46.16万 - 项目类别:
相似国自然基金
诊疗一体化PS-Hc@MB协同训练介导脑小血管病康复的作用及机制研究
- 批准号:82372561
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于自监督学习的脑电特征表达预训练模型研究
- 批准号:62376098
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
HMGCS2调控巨噬细胞训练免疫对动脉粥样硬化斑块“维稳”的机制研究
- 批准号:82373884
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
面向开放环境的现实人物检索及其分布式并行训练方法研究
- 批准号:62302161
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
深度神经网络的超图表征学习、训练优化与鲁棒性研究
- 批准号:62376153
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
胆红素分解代谢诱导纤溶酶原激活剂抑制剂 1 (PAI-1) 恶化代谢功能障碍
- 批准号:
10750132 - 财政年份:2024
- 资助金额:
$ 46.16万 - 项目类别:
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
- 批准号:
10557638 - 财政年份:2023
- 资助金额:
$ 46.16万 - 项目类别:
Experiences of Discrimination, Dysbiosis, and Racial Disparities in Ovarian Cancer
卵巢癌中的歧视、生态失调和种族差异的经历
- 批准号:
10371537 - 财政年份:2023
- 资助金额:
$ 46.16万 - 项目类别:
Thick and Thin Filament Dysfunction in Obese Heart Failure with Preserved Ejection Fraction
射血分数保留的肥胖性心力衰竭的粗细丝功能障碍
- 批准号:
10678204 - 财政年份:2023
- 资助金额:
$ 46.16万 - 项目类别:
Advancing Student Potential for Inclusion with Research Experiences (ASPIRE)
通过研究经验提升学生融入的潜力(ASPIRE)
- 批准号:
10678356 - 财政年份:2023
- 资助金额:
$ 46.16万 - 项目类别: